{"success":true,"data":{"pressRelease":{"id":"166543","rtpr_id":"nGNXsmFJt-20261012","ticker":"AXP","exchange":"NYSE","all_tickers":["AXP","CCB","DUOL","ERAS"],"title":"Attention Long-Term Shareholders of American Express Company (NYSE: AXP); Coastal Financial Corporation (NASDAQ: CCB); Duolingo, Inc. (NASDAQ: DUOL); and Erasca, Inc. (NASDAQ: ERAS): Grabar Law Office is Investigating Claims on Your Behalf","author":"Globe Newswire","published_at":"2026-10-12T14:20:11.134Z","article_body":"PHILADELPHIA, Oct. 12, 2026 (GLOBE NEWSWIRE) --\n\nAmerican Express Company (NYSE: AXP):\n\nCurrent American Express Company (NYSE: AXP) shareholders who have held\nAmerican Express shares continuously since prior to June 2014 are encouraged\nto visit https://grabarlaw.com/the-latest/axp-shareholder-investigation/,\ncontact Joshua Grabar of Grabar Law Office at jgrabar@grabarlaw.com, or call\n267-587-8085 to learn more about the investigation. You can seek corporate\ngovernance reforms, recovery of losses sustained by the Company, and a court\napproved incentive award at absolutely no cost to you whatsoever.\n\nWhat is Happening? Grabar Law Office is investigating claims on behalf of\nlong-term shareholders of American Express Company (NYSE: AXP) concerning\nwhether certain officers and directors breached fiduciary duties owed to the\nCompany in connection with alleged deficiencies in the Bank Secrecy Act and\nanti-money laundering compliance program of its banking subsidiary, American\nExpress National Bank.\n\nWhy? On October 8, 2026, the Office of the Comptroller of the Currency\n(“OCC”) issued a Consent Order against American Express National Bank\nrelating to deficiencies in the Bank’s Bank Secrecy Act/anti-money\nlaundering (“BSA/AML”) compliance program. The OCC stated that the\ndeficiencies resulted in violations involving the Bank’s BSA/AML program,\nsuspicious activity reporting, customer due diligence, and customer\nidentification procedures.\n\nAccording to the OCC, the Bank failed to establish and maintain a reasonably\ndesigned BSA/AML compliance program and had systemic internal-control gaps,\nweaknesses in independent testing, and deficiencies in BSA/AML training. The\nOCC further identified deficiencies relating to customer due diligence,\ncustomer identification procedures, suspicious-activity monitoring and\nreporting, internal audit, staffing and training.\n\nOCC Identifies Approximately $13 Billion in Suspected Trade-Based Money\nLaundering Activity: Of particular significance, the OCC found that\ndeficiencies in the Bank’s BSA/AML compliance program contributed to its\nfailure to timely identify, evaluate and sufficiently report suspicious\nactivity associated with suspected trade-based money laundering (“TBML”).\n\nAccording to the OCC:\n\nFrom approximately June 2014 through approximately May 2025, American Express\nNational Bank processed approximately $13 billion in suspected TBML activity,\nincluding suspicious card charges and repayments of those charges.\n\nThe OCC further stated that some of this activity occurred through accounts\nassociated with Bank insiders, and that although the Bank periodically\nreported suspicious activity during this period, it lacked the internal\ncontrols and monitoring capabilities necessary to timely identify and report\nthe full scope of the activity.\n\nThe OCC found that these deficiencies resulted in violations of\nBSA/AML-related regulations and stated that the violations were part of a\npattern of misconduct and caused more than a minimal loss to the Bank.\n\nOCC Requires Significant Remedial Measures and Board Oversight: The Consent\nOrder requires American Express National Bank to undertake substantial\ncorrective measures, including, among other things, the Bank must establish a\ncompliance committee to oversee compliance with the Order and provide detailed\nquarterly reports to the Board concerning required and completed corrective\nactions.\n\nThe Bank also must develop a written action plan addressing the identified\ndeficiencies and establish or enhance programs governing:\n* BSA/AML risk assessment;\n* customer due diligence and customer identification;\n* financial-crimes risk management;\n* suspicious-activity identification, investigation and reporting;\n* independent BSA/AML testing;\n* BSA/AML staffing and expertise;\n* employee and director training; and\n* monitoring of suspicious activity involving Bank insiders.\nThe Order further directs the Board to ensure that the required corrective\nactions are implemented and effective and to hold Bank management and\npersonnel accountable for carrying out their responsibilities under the Order.\n\nWhat Can Long-Term American Express Shareholders Do? Current long-term\nAmerican Express Company (NYSE: AXP) shareholders who have continuously held\nshares since prior to June 2014, you are encouraged to visit\nhttps://grabarlaw.com/the-latest/axp-shareholder-investigation/, contact\nJoshua Grabar at jgrabar@grabarlaw.com, or call 267-507-6085. You can pursue\nclaims on behalf of the Company seeking corporate governance reforms, recovery\nof losses sustained by the Company, the return of compensation or other\nbenefits where appropriate, at no cost to you whatsoever. #AXP $AXP\n\nCoastal Financial Corporation (NASDAQ: CCB):\n\nGrabar Law Office is investigating claims on behalf of shareholders of Coastal\nFinancial Corporation (NASDAQ: CCB).\n\nWhat is This Investigation About? This investigation concerns possible\nbreaches of fiduciary duties and other alleged misconduct by certain officers\nand directors of the Company.\n\nCurrent Coastal Financial Corporation (NASDAQ: CCB) shareholders who have held\nCoastal shares since prior to October 28, 2024, are encouraged visit\nhttps://grabarlaw.com/the-latest/coastal-shareholder-investigation/, contact\nJoshua Grabar at jgrabar@grabarlaw.com, or call 267-507-6085. You can seek\ncorporate reforms, the return of funds spent defending litigation back to the\ncompany, and a court approved incentive award, at no cost to you whatsoever.\n\nWhat is Alleged? A recently filed federal securities fraud class action\nalleges that Coastal Financial Corporation (NASDAQ: CCB), through certain of\nits current and former executives, made materially false and misleading\nstatements concerning the growth and credit quality of Coastal’s CCBX\nbusiness, the adequacy of the Company’s risk-management and\ncredit-monitoring practices, and the credit protections provided by CCBX\npartner indemnification agreements.\n\nSpecifically, that complaint alleges that, while Coastal represented that CCBX\ngrowth was being pursued in a disciplined manner with an emphasis on credit\nquality and risk management, defendants failed to disclose that: 1) the credit\nquality of a substantial CCBX partner loan portfolio consisting of\napproximately $500 million in loans, or nearly 23% of all CCBX loans, had\nmaterially deteriorated; 2) the deterioration exposed Coastal to significant\ncredit losses despite representations concerning the protections provided by\nCCBX partner indemnification agreements; and 3) Coastal’s risk-management\nand credit-monitoring practices were allegedly inadequate to identify,\nproperly account for and mitigate the deterioration and resulting risks.\n\nThe underlying complaint further alleges that Coastal repeatedly emphasized\nits investment in risk management and its contractual protection from CCBX\ncredit losses. For example, in April 2025 Coastal represented that it remained\nfully indemnified against fraud and 98.8% indemnified against credit risk with\nits CCBX partners, and the Company made a similar representation as of March\n31, 2026. Then, on July 30, 2026, Coastal announced its second-quarter 2026\nfinancial results and reported a surprise GAAP net loss of $42.1 million,\ndriven primarily by a $68.8 million credit expense associated with a single\nCCBX partner relationship. According to the complaint, the $68.8 million\nexpense consisted of: 1) a $46 million valuation adjustment to the related\ncredit-enhancement asset; and 2) a $22.8 million provision for credit losses\nassociated with the partner’s indemnification obligations.\n\nIt is further alleged that Coastal also disclosed that the affected portfolio\nconsisted of approximately $500 million in underlying loans, together with the\nrelated reimbursement exposure. Following these disclosures, Coastal common\nstock fell $30.75 per share, or 43.5%, closing at $39.91 per share on July 30,\n2026. According to the complaint, the decline erased approximately $470\nmillion in market capitalization.\n\nThe complaint additionally alleges that Chief Executive Officer Eric M. Sprink\nsold approximately $12 million of Coastal common stock during the Class\nPeriod, while former CFO Joel Edwards sold approximately $3.8 million. It is\nalleged that those sales occurred before the deterioration of the CCBX partner\nportfolio and Coastal’s resulting exposure were disclosed to investors.\n\nWhat Can You Do Now? If you have owned Coastal Financial Corporation (NASDAQ:\nCCB) shares since prior to October 28, 2024, you can seek corporate reforms,\nthe return of funds spent defending litigation back to the company, and a\ncourt approved incentive award, at no cost to you whatsoever. Please visit\nhttps://grabarlaw.com/the-latest/coastal-shareholder-investigation/, contact\nJoshua Grabar at jgrabar@grabarlaw.com, or call 267-507-6085 to learn more.\n#CoastalFinancial #CCB $CCB\n\nDuolingo, Inc. (NASDAQ: DUOL):\n\nCurrent Duolingo, Inc. shareholders who have held Duolingo shares since prior\nto May 2, 2025, are encouraged to contact Grabar Law Office to learn more\nabout the investigation.\n\nWhat is The Investigation About? Grabar Law Office is investigating claims on\nbehalf of long-term shareholders of Duolingo, Inc. (NASDAQ: DUOL) concerning\nwhether certain officers and directors of the Company breached fiduciary\nduties owed to Duolingo and its shareholders.\n\nIf you currently own Duolingo, Inc. (NASDAQ: DUOL) shares and have held those\nshares since prior to May 2, 2025, please visit\nhttps://grabarlaw.com/the-latest/duolingo-shareholder-investigation/, contact\nus at jgrabar@grabarlaw.com, or call 267-507-6085. you can seek corporate\nreforms, the return of funds spent defending litigation back to the company,\nand a court approved incentive award, at no cost to you whatsoever.\n\nWhy? As alleged in a federal securities fraud class action complaint,\nDuolingo, Inc.’s (NASDAQ: DUOL) growth strategy increasingly emphasized\nmonetization through advertising, subscription-tier upselling and the use of\nrapidly generated artificial-intelligence content. In this context it is\nalleged that the company, through certain corporate officers made materially\nfalse or misleading statements and/or failed to disclose that: 1) Duolingo was\ndeliberately increasing user “friction” through higher advertising volume\nand subscription upsells; 2) the Company’s extensive A/B testing allegedly\nshowed that such friction was negatively affecting daily active user, or DAU,\ngrowth; 3) rapidly generated AI content was allegedly degrading the quality of\nDuolingo’s product offerings and user experience; and 4) the Company’s\nmonetization strategy and lower-quality AI-generated content were allegedly\nundermining the sustainability of Duolingo’s growth and financial\nperformance.\n\nThe complaint further alleges that, in April 2025, Duolingo introduced a new\nfeature known as Energy, which replaced its prior Hearts system. According to\nthe complaint, the Energy system was designed in part to create additional\nfriction for free users and encourage them to convert to paid subscriptions,\nwhile Duolingo publicly characterized the feature as rewarding and beneficial\nto user engagement.\n\nThe complaint also alleges that Duolingo increasingly relied upon AI-generated\ncontent while representing to investors that its use of AI was improving the\nproduct and accelerating content creation. According to the complaint, users\ninstead began reporting translation and pronunciation errors, repetitive\nlessons and other quality concerns associated with certain AI-powered\nfeatures.\n\nWhat Can Long-Term Duolingo Shareholders Do Now? If you currently own\nDuolingo, Inc. (NASDAQ: DUOL) shares and have held those shares since prior to\nMay 2, 2025, you can seek corporate reforms, the return of funds spent\ndefending litigation back to the company, and a court approved incentive\naward, at no cost to you whatsoever. If you would like to learn more about\nthis matter, you are encouraged to visit\nhttps://grabarlaw.com/the-latest/duolingo-shareholder-investigation/, contact\nus at jgrabar@grabarlaw.com, or call 267-507-6085. #Duol $DUOL #Duolingo\n\nErasca, Inc. (NASDAQ: ERAS):\n\nGrabar Law Office is investigating whether certain officers and directors of\nErasca, Inc. (NASDAQ: ERAS) breached their fiduciary duties owed to the\nCompany and its shareholders.\n\nWhat is This Investigation About? The investigation concerns whether Erasca's\ndirectors and senior executives maintained appropriate oversight, disclosure\ncontrols, compliance procedures, and risk-management systems relating to the\nCompany's public statements concerning ERAS-0015, a pan-RAS molecular glue\ncandidate being developed for the treatment of RAS-mutant solid tumors.\n\nIf you are a current Erasca (NASDAQ: ERAS) shareholder who has held shares\nsince prior to January 14, 2025, you seek corporate governance reforms,\ndamages on behalf of the Company, and a court approved incentive award at no\ncost to you whatsoever. Please visit\nhttps://grabarlaw.com/the-latest/erasca-shareholder-investigation/, contact\nJoshua H. Grabar at jgrabar@grabarlaw.com, or call us at 267-507-6085.\n\nWhat is Alleged? According to a recently filed federal securities class action\nErasca, Inc. (NASDAQ: ERAS), through certain of its officers, made materially\nmisleading statements and omissions concerning ERAS-0015. Among other things,\nthe underlying class action complaint alleges that: Erasca publicly promoted\nERAS-0015 as a potential \"best-in-class\" therapy and made repeated comparisons\nbetween ERAS-0015 and Revolution Medicines' RMC-6236; the Company's public\ndisclosures allegedly relied upon improper comparisons to RMC-6236; Erasca\nallegedly faced intellectual property, patent, and trade-secret-related risks\nassociated with those comparisons and related disclosures; investors allegedly\nwere not adequately informed of those risks; and certain positive statements\nregarding ERAS-0015 allegedly lacked a reasonable basis when made.\n\nApril 2026 Disclosures: On April 27, 2026, Erasca disclosed that it had\nreceived correspondence from counsel for Revolution Medicines alleging, among\nother things, patent infringement, trade-secret-related issues, and allegedly\nimproper comparative statements concerning ERAS-0015 and RMC-6236. Later that\nsame day, Erasca disclosed preliminary Phase 1 clinical data regarding\nERAS-0015 and reported that one patient who received ERAS-0015 had died after\nexperiencing pneumonitis that progressed following withdrawal of supportive\ncare. The Company also disclosed that comparisons between ERAS-0015 and other\nproduct candidates were based on cross-study analyses rather than head-to-head\nclinical trials and that such comparisons were inherently limited. Following\nthese disclosures, Erasca's share price experienced a substantial decline.\n\nWhat Can You Do Now? If you are a current Erasca, Inc. (NASDAQ: ERAS)\nshareholder and have held shares since prior to January 14, 2025, you can seek\ncorporate governance reforms, damages on behalf of the Company, and a court\napproved incentive award at no cost to you whatsoever. Please visit\nhttps://grabarlaw.com/the-latest/erasca-shareholder-investigation/, contact\nJoshua H. Grabar at jgrabar@grabarlaw.com, or call us at 267-507-6085. #Erasca\n#ERAS $ERAS\n\nAttorney Advertising Disclaimer\n(https://www.globenewswire.com/Tracker?data=YCWd01BLeJ9MNqao61CsewWpmF4F5H28afr_5X_Mwx1K7bJVmb2RTcRKaLAA_v3bt1MDeHLs_-0Qd8Oa0gmnWoUPSWVz7W394Wfv41nG7ls9B47qKT2OR2KBUoWl221SDkddOUEDJExdRl6aPKpNUCCDcIfpbGxL2wE-6KT2F_Q=)\n\nContact:\nJoshua H. Grabar, Esq.\nGrabar Law Office\nOne Liberty Place\n1650 Market Street, Suite 3600\nPhiladelphia, PA 19103\nTel: 267-507-6085\nEmail: jgrabar@grabarlaw.com\n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/6c801a52-ae63-4c0d-a62c-5713903ad05d)\n\n\n\nGlobeNewswire, Inc. 2026","article_body_html":"","raw_payload":{"data":{"id":"nGNXsmFJt-20261012","title":"Attention Long-Term Shareholders of American Express Company (NYSE: AXP); Coastal Financial Corporation (NASDAQ: CCB); Duolingo, Inc. (NASDAQ: DUOL); and Erasca, Inc. (NASDAQ: ERAS): Grabar Law Office is Investigating Claims on Your Behalf","author":"Globe Newswire","ticker":"AXP","created":"2026-10-12T14:20:11.134Z","tickers":["AXP","CCB","DUOL","ERAS"],"exchange":"NYSE","article_body":"PHILADELPHIA, Oct. 12, 2026 (GLOBE NEWSWIRE) --\n\nAmerican Express Company (NYSE: AXP):\n\nCurrent American Express Company (NYSE: AXP) shareholders who have held\nAmerican Express shares continuously since prior to June 2014 are encouraged\nto visit https://grabarlaw.com/the-latest/axp-shareholder-investigation/,\ncontact Joshua Grabar of Grabar Law Office at jgrabar@grabarlaw.com, or call\n267-587-8085 to learn more about the investigation. You can seek corporate\ngovernance reforms, recovery of losses sustained by the Company, and a court\napproved incentive award at absolutely no cost to you whatsoever.\n\nWhat is Happening? Grabar Law Office is investigating claims on behalf of\nlong-term shareholders of American Express Company (NYSE: AXP) concerning\nwhether certain officers and directors breached fiduciary duties owed to the\nCompany in connection with alleged deficiencies in the Bank Secrecy Act and\nanti-money laundering compliance program of its banking subsidiary, American\nExpress National Bank.\n\nWhy? On October 8, 2026, the Office of the Comptroller of the Currency\n(“OCC”) issued a Consent Order against American Express National Bank\nrelating to deficiencies in the Bank’s Bank Secrecy Act/anti-money\nlaundering (“BSA/AML”) compliance program. The OCC stated that the\ndeficiencies resulted in violations involving the Bank’s BSA/AML program,\nsuspicious activity reporting, customer due diligence, and customer\nidentification procedures.\n\nAccording to the OCC, the Bank failed to establish and maintain a reasonably\ndesigned BSA/AML compliance program and had systemic internal-control gaps,\nweaknesses in independent testing, and deficiencies in BSA/AML training. The\nOCC further identified deficiencies relating to customer due diligence,\ncustomer identification procedures, suspicious-activity monitoring and\nreporting, internal audit, staffing and training.\n\nOCC Identifies Approximately $13 Billion in Suspected Trade-Based Money\nLaundering Activity: Of particular significance, the OCC found that\ndeficiencies in the Bank’s BSA/AML compliance program contributed to its\nfailure to timely identify, evaluate and sufficiently report suspicious\nactivity associated with suspected trade-based money laundering (“TBML”).\n\nAccording to the OCC:\n\nFrom approximately June 2014 through approximately May 2025, American Express\nNational Bank processed approximately $13 billion in suspected TBML activity,\nincluding suspicious card charges and repayments of those charges.\n\nThe OCC further stated that some of this activity occurred through accounts\nassociated with Bank insiders, and that although the Bank periodically\nreported suspicious activity during this period, it lacked the internal\ncontrols and monitoring capabilities necessary to timely identify and report\nthe full scope of the activity.\n\nThe OCC found that these deficiencies resulted in violations of\nBSA/AML-related regulations and stated that the violations were part of a\npattern of misconduct and caused more than a minimal loss to the Bank.\n\nOCC Requires Significant Remedial Measures and Board Oversight: The Consent\nOrder requires American Express National Bank to undertake substantial\ncorrective measures, including, among other things, the Bank must establish a\ncompliance committee to oversee compliance with the Order and provide detailed\nquarterly reports to the Board concerning required and completed corrective\nactions.\n\nThe Bank also must develop a written action plan addressing the identified\ndeficiencies and establish or enhance programs governing:\n* BSA/AML risk assessment;\n* customer due diligence and customer identification;\n* financial-crimes risk management;\n* suspicious-activity identification, investigation and reporting;\n* independent BSA/AML testing;\n* BSA/AML staffing and expertise;\n* employee and director training; and\n* monitoring of suspicious activity involving Bank insiders.\nThe Order further directs the Board to ensure that the required corrective\nactions are implemented and effective and to hold Bank management and\npersonnel accountable for carrying out their responsibilities under the Order.\n\nWhat Can Long-Term American Express Shareholders Do? Current long-term\nAmerican Express Company (NYSE: AXP) shareholders who have continuously held\nshares since prior to June 2014, you are encouraged to visit\nhttps://grabarlaw.com/the-latest/axp-shareholder-investigation/, contact\nJoshua Grabar at jgrabar@grabarlaw.com, or call 267-507-6085. You can pursue\nclaims on behalf of the Company seeking corporate governance reforms, recovery\nof losses sustained by the Company, the return of compensation or other\nbenefits where appropriate, at no cost to you whatsoever. #AXP $AXP\n\nCoastal Financial Corporation (NASDAQ: CCB):\n\nGrabar Law Office is investigating claims on behalf of shareholders of Coastal\nFinancial Corporation (NASDAQ: CCB).\n\nWhat is This Investigation About? This investigation concerns possible\nbreaches of fiduciary duties and other alleged misconduct by certain officers\nand directors of the Company.\n\nCurrent Coastal Financial Corporation (NASDAQ: CCB) shareholders who have held\nCoastal shares since prior to October 28, 2024, are encouraged visit\nhttps://grabarlaw.com/the-latest/coastal-shareholder-investigation/, contact\nJoshua Grabar at jgrabar@grabarlaw.com, or call 267-507-6085. You can seek\ncorporate reforms, the return of funds spent defending litigation back to the\ncompany, and a court approved incentive award, at no cost to you whatsoever.\n\nWhat is Alleged? A recently filed federal securities fraud class action\nalleges that Coastal Financial Corporation (NASDAQ: CCB), through certain of\nits current and former executives, made materially false and misleading\nstatements concerning the growth and credit quality of Coastal’s CCBX\nbusiness, the adequacy of the Company’s risk-management and\ncredit-monitoring practices, and the credit protections provided by CCBX\npartner indemnification agreements.\n\nSpecifically, that complaint alleges that, while Coastal represented that CCBX\ngrowth was being pursued in a disciplined manner with an emphasis on credit\nquality and risk management, defendants failed to disclose that: 1) the credit\nquality of a substantial CCBX partner loan portfolio consisting of\napproximately $500 million in loans, or nearly 23% of all CCBX loans, had\nmaterially deteriorated; 2) the deterioration exposed Coastal to significant\ncredit losses despite representations concerning the protections provided by\nCCBX partner indemnification agreements; and 3) Coastal’s risk-management\nand credit-monitoring practices were allegedly inadequate to identify,\nproperly account for and mitigate the deterioration and resulting risks.\n\nThe underlying complaint further alleges that Coastal repeatedly emphasized\nits investment in risk management and its contractual protection from CCBX\ncredit losses. For example, in April 2025 Coastal represented that it remained\nfully indemnified against fraud and 98.8% indemnified against credit risk with\nits CCBX partners, and the Company made a similar representation as of March\n31, 2026. Then, on July 30, 2026, Coastal announced its second-quarter 2026\nfinancial results and reported a surprise GAAP net loss of $42.1 million,\ndriven primarily by a $68.8 million credit expense associated with a single\nCCBX partner relationship. According to the complaint, the $68.8 million\nexpense consisted of: 1) a $46 million valuation adjustment to the related\ncredit-enhancement asset; and 2) a $22.8 million provision for credit losses\nassociated with the partner’s indemnification obligations.\n\nIt is further alleged that Coastal also disclosed that the affected portfolio\nconsisted of approximately $500 million in underlying loans, together with the\nrelated reimbursement exposure. Following these disclosures, Coastal common\nstock fell $30.75 per share, or 43.5%, closing at $39.91 per share on July 30,\n2026. According to the complaint, the decline erased approximately $470\nmillion in market capitalization.\n\nThe complaint additionally alleges that Chief Executive Officer Eric M. Sprink\nsold approximately $12 million of Coastal common stock during the Class\nPeriod, while former CFO Joel Edwards sold approximately $3.8 million. It is\nalleged that those sales occurred before the deterioration of the CCBX partner\nportfolio and Coastal’s resulting exposure were disclosed to investors.\n\nWhat Can You Do Now? If you have owned Coastal Financial Corporation (NASDAQ:\nCCB) shares since prior to October 28, 2024, you can seek corporate reforms,\nthe return of funds spent defending litigation back to the company, and a\ncourt approved incentive award, at no cost to you whatsoever. Please visit\nhttps://grabarlaw.com/the-latest/coastal-shareholder-investigation/, contact\nJoshua Grabar at jgrabar@grabarlaw.com, or call 267-507-6085 to learn more.\n#CoastalFinancial #CCB $CCB\n\nDuolingo, Inc. (NASDAQ: DUOL):\n\nCurrent Duolingo, Inc. shareholders who have held Duolingo shares since prior\nto May 2, 2025, are encouraged to contact Grabar Law Office to learn more\nabout the investigation.\n\nWhat is The Investigation About? Grabar Law Office is investigating claims on\nbehalf of long-term shareholders of Duolingo, Inc. (NASDAQ: DUOL) concerning\nwhether certain officers and directors of the Company breached fiduciary\nduties owed to Duolingo and its shareholders.\n\nIf you currently own Duolingo, Inc. (NASDAQ: DUOL) shares and have held those\nshares since prior to May 2, 2025, please visit\nhttps://grabarlaw.com/the-latest/duolingo-shareholder-investigation/, contact\nus at jgrabar@grabarlaw.com, or call 267-507-6085. you can seek corporate\nreforms, the return of funds spent defending litigation back to the company,\nand a court approved incentive award, at no cost to you whatsoever.\n\nWhy? As alleged in a federal securities fraud class action complaint,\nDuolingo, Inc.’s (NASDAQ: DUOL) growth strategy increasingly emphasized\nmonetization through advertising, subscription-tier upselling and the use of\nrapidly generated artificial-intelligence content. In this context it is\nalleged that the company, through certain corporate officers made materially\nfalse or misleading statements and/or failed to disclose that: 1) Duolingo was\ndeliberately increasing user “friction” through higher advertising volume\nand subscription upsells; 2) the Company’s extensive A/B testing allegedly\nshowed that such friction was negatively affecting daily active user, or DAU,\ngrowth; 3) rapidly generated AI content was allegedly degrading the quality of\nDuolingo’s product offerings and user experience; and 4) the Company’s\nmonetization strategy and lower-quality AI-generated content were allegedly\nundermining the sustainability of Duolingo’s growth and financial\nperformance.\n\nThe complaint further alleges that, in April 2025, Duolingo introduced a new\nfeature known as Energy, which replaced its prior Hearts system. According to\nthe complaint, the Energy system was designed in part to create additional\nfriction for free users and encourage them to convert to paid subscriptions,\nwhile Duolingo publicly characterized the feature as rewarding and beneficial\nto user engagement.\n\nThe complaint also alleges that Duolingo increasingly relied upon AI-generated\ncontent while representing to investors that its use of AI was improving the\nproduct and accelerating content creation. According to the complaint, users\ninstead began reporting translation and pronunciation errors, repetitive\nlessons and other quality concerns associated with certain AI-powered\nfeatures.\n\nWhat Can Long-Term Duolingo Shareholders Do Now? If you currently own\nDuolingo, Inc. (NASDAQ: DUOL) shares and have held those shares since prior to\nMay 2, 2025, you can seek corporate reforms, the return of funds spent\ndefending litigation back to the company, and a court approved incentive\naward, at no cost to you whatsoever. If you would like to learn more about\nthis matter, you are encouraged to visit\nhttps://grabarlaw.com/the-latest/duolingo-shareholder-investigation/, contact\nus at jgrabar@grabarlaw.com, or call 267-507-6085. #Duol $DUOL #Duolingo\n\nErasca, Inc. (NASDAQ: ERAS):\n\nGrabar Law Office is investigating whether certain officers and directors of\nErasca, Inc. (NASDAQ: ERAS) breached their fiduciary duties owed to the\nCompany and its shareholders.\n\nWhat is This Investigation About? The investigation concerns whether Erasca's\ndirectors and senior executives maintained appropriate oversight, disclosure\ncontrols, compliance procedures, and risk-management systems relating to the\nCompany's public statements concerning ERAS-0015, a pan-RAS molecular glue\ncandidate being developed for the treatment of RAS-mutant solid tumors.\n\nIf you are a current Erasca (NASDAQ: ERAS) shareholder who has held shares\nsince prior to January 14, 2025, you seek corporate governance reforms,\ndamages on behalf of the Company, and a court approved incentive award at no\ncost to you whatsoever. Please visit\nhttps://grabarlaw.com/the-latest/erasca-shareholder-investigation/, contact\nJoshua H. Grabar at jgrabar@grabarlaw.com, or call us at 267-507-6085.\n\nWhat is Alleged? According to a recently filed federal securities class action\nErasca, Inc. (NASDAQ: ERAS), through certain of its officers, made materially\nmisleading statements and omissions concerning ERAS-0015. Among other things,\nthe underlying class action complaint alleges that: Erasca publicly promoted\nERAS-0015 as a potential \"best-in-class\" therapy and made repeated comparisons\nbetween ERAS-0015 and Revolution Medicines' RMC-6236; the Company's public\ndisclosures allegedly relied upon improper comparisons to RMC-6236; Erasca\nallegedly faced intellectual property, patent, and trade-secret-related risks\nassociated with those comparisons and related disclosures; investors allegedly\nwere not adequately informed of those risks; and certain positive statements\nregarding ERAS-0015 allegedly lacked a reasonable basis when made.\n\nApril 2026 Disclosures: On April 27, 2026, Erasca disclosed that it had\nreceived correspondence from counsel for Revolution Medicines alleging, among\nother things, patent infringement, trade-secret-related issues, and allegedly\nimproper comparative statements concerning ERAS-0015 and RMC-6236. Later that\nsame day, Erasca disclosed preliminary Phase 1 clinical data regarding\nERAS-0015 and reported that one patient who received ERAS-0015 had died after\nexperiencing pneumonitis that progressed following withdrawal of supportive\ncare. The Company also disclosed that comparisons between ERAS-0015 and other\nproduct candidates were based on cross-study analyses rather than head-to-head\nclinical trials and that such comparisons were inherently limited. Following\nthese disclosures, Erasca's share price experienced a substantial decline.\n\nWhat Can You Do Now? If you are a current Erasca, Inc. (NASDAQ: ERAS)\nshareholder and have held shares since prior to January 14, 2025, you can seek\ncorporate governance reforms, damages on behalf of the Company, and a court\napproved incentive award at no cost to you whatsoever. Please visit\nhttps://grabarlaw.com/the-latest/erasca-shareholder-investigation/, contact\nJoshua H. Grabar at jgrabar@grabarlaw.com, or call us at 267-507-6085. #Erasca\n#ERAS $ERAS\n\nAttorney Advertising Disclaimer\n(https://www.globenewswire.com/Tracker?data=YCWd01BLeJ9MNqao61CsewWpmF4F5H28afr_5X_Mwx1K7bJVmb2RTcRKaLAA_v3bt1MDeHLs_-0Qd8Oa0gmnWoUPSWVz7W394Wfv41nG7ls9B47qKT2OR2KBUoWl221SDkddOUEDJExdRl6aPKpNUCCDcIfpbGxL2wE-6KT2F_Q=)\n\nContact:\nJoshua H. Grabar, Esq.\nGrabar Law Office\nOne Liberty Place\n1650 Market Street, Suite 3600\nPhiladelphia, PA 19103\nTel: 267-507-6085\nEmail: jgrabar@grabarlaw.com\n\n(https://www.globenewswire.com/NewsRoom/AttachmentNg/6c801a52-ae63-4c0d-a62c-5713903ad05d)\n\n\n\nGlobeNewswire, Inc. 2026"},"type":"article","timestamp":"2026-10-12T14:20:11.187418848Z","server_sent_at_ms":1791814811187},"received_at":"2026-10-12T14:20:11.357Z","source_url":null},"analysis":{"id":"154889","press_release_id":"166543","analysis_json":{"industry":{"label":"Consumer Finance","sector":"Financials"},"redFlags":["references unremediated OCC consent order against American Express National Bank over BSA/AML compliance"],"eventType":"legal_litigation","narrative":"Grabar Law Office issued a multi-company shareholder-solicitation release naming American Express, Coastal Financial, Duolingo, and Erasca; no new disclosure comes from any of the issuers themselves.\n\nFor AXP, the release recaps an October 8, 2026 OCC consent order over BSA/AML compliance deficiencies, citing roughly $13 billion in suspected trade-based money laundering processed from 2014 to 2025.\n\nThis is attorney advertising soliciting long-term shareholders to pursue derivative-style claims at no cost; it is law-firm marketing, not an issuer or court action.","sentiment":"neutral","agentHooks":{"shouldPost":false,"suggestedAngle":"Plaintiff-firm solicitation -- suppress; note OCC consent order reference for separate regulatory-event tracking."},"keyFigures":{},"namedEntities":{"people":[{"name":"Joshua H. Grabar","role":"attorney, Grabar Law Office"},{"name":"Eric M. Sprink","role":"CEO of Coastal Financial Corporation (alleged)"},{"name":"Joel Edwards","role":"former CFO of Coastal Financial Corporation (alleged)"}],"products":["ERAS-0015","RMC-6236","CCBX","Energy"],"companies":[{"name":"Grabar Law Office","relationship":"plaintiff law firm"},{"name":"American Express Company","ticker":"AXP","relationship":"investigation target"},{"name":"Coastal Financial Corporation","ticker":"CCB","relationship":"investigation target"},{"name":"Duolingo, Inc.","ticker":"DUOL","relationship":"investigation target"},{"name":"Erasca, Inc.","ticker":"ERAS","relationship":"investigation target"},{"name":"Revolution Medicines","relationship":"mentioned (comparative-claims allegation)"}],"dollarAmounts":[{"amount":"$13 billion","context":"suspected trade-based money laundering activity processed by American Express National Bank per OCC"},{"amount":"$500 million","context":"CCBX partner loan portfolio at Coastal Financial"},{"amount":"$42.1 million","context":"Coastal Q2 2026 GAAP net loss"},{"amount":"$68.8 million","context":"Coastal credit expense tied to single CCBX partner"},{"amount":"$470 million","context":"market capitalization erased in Coastal selloff"},{"amount":"$12 million","context":"alleged insider sales by Coastal CEO"},{"amount":"$3.8 million","context":"alleged insider sales by former Coastal CFO"}]},"materialImpact":{"score":1,"reasoning":"Plaintiff law-firm solicitation by Grabar Law Office covering four issuers (AXP, CCB, DUOL, ERAS). No new issuer disclosure; no certified class or settlement. The underlying OCC consent order against AXP is referenced but is not the issuer's own release."},"tickerRelevance":{"others":[{"ticker":"CCB","relevance":"co-investigation target in multi-company solicitation"},{"ticker":"DUOL","relevance":"co-investigation target in multi-company solicitation"},{"ticker":"ERAS","relevance":"co-investigation target in multi-company solicitation"}],"primary":"AXP"},"globalImportance":15,"audienceRelevance":20,"eventTypeSecondary":[],"importanceComponents":{"tickerTier":"large-cap-primary","eventGravity":"law-firm-solicitation","issuerAuthored":false,"multiIssuerRelease":true}},"event_type":"legal_litigation","event_type_secondary":null,"sentiment":"neutral","material_impact_score":1,"narrative":"Grabar Law Office issued a multi-company shareholder-solicitation release naming American Express, Coastal Financial, Duolingo, and Erasca; no new disclosure comes from any of the issuers themselves.\n\nFor AXP, the release recaps an October 8, 2026 OCC consent order over BSA/AML compliance deficiencies, citing roughly $13 billion in suspected trade-based money laundering processed from 2014 to 2025.\n\nThis is attorney advertising soliciting long-term shareholders to pursue derivative-style claims at no cost; it is law-firm marketing, not an issuer or court action.","key_figures":{},"named_entities":{"people":[{"name":"Joshua H. Grabar","role":"attorney, Grabar Law Office"},{"name":"Eric M. Sprink","role":"CEO of Coastal Financial Corporation (alleged)"},{"name":"Joel Edwards","role":"former CFO of Coastal Financial Corporation (alleged)"}],"products":["ERAS-0015","RMC-6236","CCBX","Energy"],"companies":[{"name":"Grabar Law Office","relationship":"plaintiff law firm"},{"name":"American Express Company","ticker":"AXP","relationship":"investigation target"},{"name":"Coastal Financial Corporation","ticker":"CCB","relationship":"investigation target"},{"name":"Duolingo, Inc.","ticker":"DUOL","relationship":"investigation target"},{"name":"Erasca, Inc.","ticker":"ERAS","relationship":"investigation target"},{"name":"Revolution Medicines","relationship":"mentioned (comparative-claims allegation)"}],"dollarAmounts":[{"amount":"$13 billion","context":"suspected trade-based money laundering activity processed by American Express National Bank per OCC"},{"amount":"$500 million","context":"CCBX partner loan portfolio at Coastal Financial"},{"amount":"$42.1 million","context":"Coastal Q2 2026 GAAP net loss"},{"amount":"$68.8 million","context":"Coastal credit expense tied to single CCBX partner"},{"amount":"$470 million","context":"market capitalization erased in Coastal selloff"},{"amount":"$12 million","context":"alleged insider sales by Coastal CEO"},{"amount":"$3.8 million","context":"alleged insider sales by former Coastal CFO"}]},"model_name":"glm-5.3-flashx","prompt_hash":"sha256:5c812bd9e28b810d","schema_hash":"sha256:05005c02d9cffac9","created_at":"2026-10-12T14:20:17.369Z","global_importance":15,"audience_relevance":20,"importance_components":{"tickerTier":"large-cap-primary","eventGravity":"law-firm-solicitation","issuerAuthored":false,"multiIssuerRelease":true}},"durationMs":5986,"modelName":"glm-5.3-flashx"}}